RC
Ryan Cohlhepp sold $401K of BCAX stock
Ryan Cohlhepp, President, COO & Interim CEO of Bicara Therapeutics Inc. (BCAX), sold 17,500 shares of BCAX stock worth $401K, per an SEC Form 4 filed Sep 10, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 8, 2026, 2 days before it was made public.
BCAX has moved -61.5% since the trade date, from $23.71 to $9.12 (Nov 19, 2026 close).
- Traded
- Sep 8, 2026
- Disclosed
- Sep 10, 2026
- Filing delay
- 2 days
- Price since
- -61.5%
- Role
- President, COO & Interim CEO
- Source
- SEC Form 4